Inspire Medical Systems, Inc. (INSP) is a Healthcare stock trading at $42.63 (as of 2026-06-18), with a market capitalization of $1.19B and a trailing P/E of 9.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Inspire Medical Systems, Inc. develops and commercializes minimally invasive therapies for obstructive sleep apnea, including its Inspire system for delivering neurostimulation to maintain an open airway. The company also works on a closed-loop approach that monitors breathing and provides hypoglossal nerve stimulation, serving patients in the United States and internationally.